TIM-3 therapy for Alzheimer’s is an innovative approach that leverages insights from cancer immune therapy to combat one of the most devastating neurodegenerative diseases.Recent research has shown that targeting the TIM-3 checkpoint molecule can rejuvenate brain immune cells known as microglia, enhancing their ability to clear amyloid plaques that contribute to cognitive decline.